Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study.Huttner A Agnandji ST Combescure C Fernandes JF Bache EB Kabwende L Ndungu FM Brosnahan J Monath TP Lemaitre B Grillet S Botto M Engler O Portmann J Siegrist D Bejon P Silvera P Kremsner P Siegrist CA Vebcon, Vsv Ebovac Vsv-Eboplus Consortia
Lancet Infect Dis, (2018). 18:738-748